Skip to main content
. Author manuscript; available in PMC: 2011 Apr 20.
Published in final edited form as: Langmuir. 2010 Apr 20;26(8):5364–5373. doi: 10.1021/la9037843

Figure 4.

Figure 4

Determination of the theranostic HBPE nanoparticles’ toxicity through the MTT assay. a) The folate-decorated Taxol-and AzT-encapsulating HBPE nanoparticles induced a significant reduction in cell (A549) viability. b) Determination of the specificity of the theranostic HBPE nanoparticles’ toxicity using H9c2 cells. Results indicated no toxicity of the HBPE nanoparticles in H9c2 cells, does not over-express folate receptor. Control cells were treated with 1× PBS. Average values of four measurements are depicted ± standard error.